Tag: Clots
Anticoagulants Do Not Reduce Arterial Thrombotic Event Risk in Cancer
No reduction seen in risk of antithrombotic events but increased risk of major and minor bleeding
Benefits of Indefinite Anticoagulant Unclear After First VTE
Indefinite anticoagulation prevented recurrent VTE events, but induced major bleeding events
Catheter-Directed Thrombolysis Beneficial for Pulmonary Embolism
Systematic review showed risk for death and major bleeding complications was lower for catheter-directed thrombolysis than systemic thrombolysis
ASCO: Direct Oral Anticoagulant Therapy Feasible for Cancer Patients
Direct oral anticoagulants noninferior to low-molecular-weight heparin for venous thromboembolism prevention
Atopic Dermatitis Tied to Higher Venous Thromboembolism Risk
While absolute risk difference is small, higher risk seen for both deep vein thrombosis and pulmonary embolism
2015 to 2019 Saw Increase in ED Use of CTPA for Suspected Pulmonary Embolism
Increase in PE diagnosis and higher proportion of low-risk PEs, with lower proportion of ICU admissions
Low Risk of Recurrent Thrombotic Events After COVID-19-Linked VTE
Risk of recurrent thrombotic events similar to that of patients with VTE linked to hospitalization for other acute medical illness
Outcomes Similar With Craniotomy, Craniectomy for Subdural Hematoma
Similar disability and quality-of-life outcomes seen with craniotomy, decompressive craniectomy for traumatic acute subdural hematoma
Young Adults, Children With Overweight Have Higher Risk for VTE in Adulthood
Individuals with young adult overweight, or overweight in childhood and young adult age have increased risk for VTE as adults
Venous Thromboembolism Risk Low in COVID-19 Outpatients
Patient-level factors, including age, sex, and body mass index, associated with higher risk
